Fairfax Financial Holdings Limited

Strong Q2 operating + investment performance (core “good”): Operating income (insurance/reinsurance, adjusted, undiscounted, before risk margin) was $1.1B in Q2 2026; underwriting income $459M vs $427M YoY; interest & dividend income $737M vs $660M (+~11%); net investment gains $769M (but noted these are volatile quarter-to-quarter). Net earnings $1.4B in Q2; $2.1B for first 6 months. Book value per share $1,304 at quarter-end (+4.8% vs year-end 2025, adjusted for the $15 dividend).

Balance-sheet actions & shareholder returns (buybacks/dividend): Fairfax bought back 680k shares for cancellation for $1.1B (~$1,601/share) during the quarter, continuing the repurchase program. The company explicitly frames BV growth as benefiting investors even with accounting items (e.g., unrealized FX translation losses). Dividend of $15/share referenced as already paid in Q1.

Major transaction wins / portfolio reshaping (opportunities/surprises): - Poseidon: sold half its position for $1.9B; pretax realized gain $838M; retains remaining half. - Kennedy-Wilson privatization: consortium led by Bill McMorrow closed in June; Fairfax invested $400M cash and contributed holdings into Kona BidCo; accounted as significant influence / equity method (no control). - Andrew Peller privatization announced: expected Q3 2026 close (~$233M or CAD 330M for Fairfax’s portion within the consortium). - Sleep Country + Sleep Number: announcement indicates Sleep Country will acquire Sleep Number (~$530M purchase price) and expand to ~800 locations across Canada/US; closing expected now / subject to court process.